H.R. 5488 (119th)Bill Overview

Special Diabetes Program for Indians Reauthorization Act of 2025

Native Americans|Native Americans
Sponsor
Cosponsors
Support
Democratic
Introduced
Sep 18, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This bill amends section 330C(c)(2) of the Public Health Service Act to add a new subparagraph providing $160,000,000 in funding for the Special Diabetes Program for Indians (SDPI) for each fiscal year 2026 through 2030, with the funds to remain available until expended. The amendment adjusts the subparagraph lettering to insert the new funding paragraph.

Why people may split

Appropriate funding level: liberals see the amount as potentially too small; conservatives view any added spending skeptically.

Watch point

Relative to its intended legislative type, this bill is a narrowly focused statutory funding authorization that is precise in its textual amendment and funding specifications but minimal in supplementary detail.

This bill amends section 330C(c)(2) of the Public Health Service Act to add a new subparagraph providing $160,000,000 in funding for the Special Diabetes Program for Indians (SDPI) for each fiscal year 2026 through 2030, with the funds to remain available until expended.

The amendment adjusts the subparagraph lettering to insert the new funding paragraph.

No other programmatic changes, offsets, or administrative details are included in the text of the bill.

Passage75/100

On content alone this is a straightforward reauthorization of an existing health program that addresses a clearly defined need for a specific population, with a moderate and bounded fiscal cost. Such bills commonly become law either on their own or as part of broader appropriations/health packages. Remaining uncertainty centers on appropriations timing and competing budget priorities rather than fundamental opposition to the underlying policy.

CredibilityAligned

Relative to its intended legislative type, this bill is a narrowly focused statutory funding authorization that is precise in its textual amendment and funding specifications but minimal in supplementary detail.

Contention30/100

Appropriate funding level: liberals see the amount as potentially too small; conservatives view any added spending skeptically.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agencies · WorkersFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Federal agenciesContinued, predictable federal funding for SDPI programs that support diabetes prevention, clinical management, educati…
  • WorkersProvides a concrete funding stream ($160 million/year; about $800 million total over 5 years) that sustains jobs for cl…
  • Potential benefitMay lower longer‑term health care expenditures by preventing or delaying costly diabetes complications (e.g., dialysis,…
Likely burdened
  • Federal agenciesCreates an explicit federal funding obligation of $160 million per year (about $800 million over FY2026–2030) that incr…
  • Potential burdenCritics may argue the authorized level is insufficient relative to the high burden of diabetes in many AI/AN communitie…
  • Federal agenciesAdministrative, reporting, or compliance requirements tied to federally administered funds may impose burdens on tribal…
03 · Why people split

Why the argument around this bill splits.

Appropriate funding level: liberals see the amount as potentially too small; conservatives view any added spending skeptically.
Progressive90%

A mainstream liberal would likely view this bill positively as a targeted investment in a well-documented health disparity affecting American Indian and Alaska Native communities.

They would see the multi-year reauthorization as providing stability for prevention and treatment programs that reduce complications from diabetes.

They may still consider the funding level modest relative to need and want stronger supports addressing social determinants of health.

Leans supportive
Centrist75%

A moderate would view the bill as a narrow, targeted reauthorization of an existing program that addresses a clear health need for a specific population.

They would appreciate the predictability of funding and the focus on prevention, while seeking assurance about fiscal responsibility and program effectiveness.

Moderates would likely weigh the program's cost against available budget offsets and desire measurable outcomes and oversight provisions.

Leans supportive
Conservative55%

A mainstream conservative would be cautiously receptive to a targeted program that serves tribal communities but would be concerned about adding recurring federal expenditures without offsets and about federal program efficiency.

They might support reauthorization on the basis of fulfilling obligations to Native communities, but prefer stricter fiscal controls, oversight, or a clearly time-limited authorization.

Some conservatives may oppose the bill solely on spending-priority grounds, while others may accept it as modest and narrowly tailored.

Split reaction
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood75/100

On content alone this is a straightforward reauthorization of an existing health program that addresses a clearly defined need for a specific population, with a moderate and bounded fiscal cost. Such bills commonly become law either on their own or as part of broader appropriations/health packages. Remaining uncertainty centers on appropriations timing and competing budget priorities rather than fundamental opposition to the underlying policy.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • The bill text authorizes funding but does not state whether the spending is mandatory or subject to annual appropriations; enactment therefore depends on the appropriations process or an explicit mandatory funding mechanism.
  • No CBO or cost estimate is included in the text provided; congressional budgeteers could influence support based on scoring and offset requirements.
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Appropriate funding level: liberals see the amount as potentially too small; conservatives view any added spending skeptically.

On content alone this is a straightforward reauthorization of an existing health program that addresses a clearly defined need for a specif…

Unlocked analysis

Relative to its intended legislative type, this bill is a narrowly focused statutory funding authorization that is precise in its textual amendment and funding specifications but minimal in supplementary detail.

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis